Regulatoriskt pressmeddelande2025-03-05 12:30BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
Regulatoriskt pressmeddelande2025-02-20 19:00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy
Regulatoriskt pressmeddelande2025-02-17 11:15BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
Regulatoriskt pressmeddelande2025-02-12 15:00BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Regulatoriskt pressmeddelande2025-02-10 07:00BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
Regulatoriskt pressmeddelande2025-02-06 13:00BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
Regulatoriskt pressmeddelande2025-01-31 14:30BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Regulatoriskt pressmeddelande2024-12-18 12:00Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatoriskt pressmeddelande2024-12-18 11:00BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatoriskt pressmeddelande2024-12-13 11:00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Regulatoriskt pressmeddelande2024-12-13 07:30BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
Video2024-12-02 14:00Life Science Companies as Investments | Life Science Night Dec. 2, 2024Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.
Regulatoriskt pressmeddelande2024-11-29 14:30BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans
Regulatoriskt pressmeddelande2024-11-29 14:20BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande2024-11-29 13:00BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company
Regulatoriskt pressmeddelande2024-11-26 15:00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande2024-11-22 17:05BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
Regulatoriskt pressmeddelande2024-11-22 17:00BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations
Regulatoriskt pressmeddelande2024-11-14 12:00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatoriskt pressmeddelande2024-11-07 11:00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
